In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort
Stéphane Éderhy, Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Franck Boccara(Inserm), Philipe Druelles(Saint Laurent Polyclinique), François Schiele(Hôpital Saint-Jacques), Meyer Elbaz(Cairo University), S. Andrieu, Denis Angoulvant(Université de Tours), Yves Cottin(CHU Dijon Bourgogne), Tabassome Simon(Sorbonne Université), Alain Furber(Université d'Angers), Nadia Aïssaoui(Université Paris Cité), Ariel Cohen(3D Biomatrix (United States)), Étienne Puymirat(Inserm), Eric Bonnefoy‐Cudraz(Hospices Civils de Lyon), Jean Ferrières(Université Fédérale de Toulouse Midi-Pyrénées)
Cited by 22
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
|Annals of Oncology|2015|897
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588